# A03-021 - Scientific Drug Profile Initialization

## Program

Program A03 - Scientific Content Population: SSRIs.

## Phase

Phase 3 - Drug Scientific Modeling.

## Sprint

Sprint 01 - Scientific Drug Profile.

## Mission

Initialize the official structural Scientific Drug Profiles for the core SSRI portfolio.

## Objective

Create profile shells that can later receive scientific-domain content through controlled missions with field-level traceability.

This mission does not extract literature, interpret evidence, populate pharmacology, create recommendations or expose knowledge to runtime.

## CTO Correction Applied

The previous Phase 3 queue repeated identification, nomenclature, classification and metadata work already handled in earlier phases.

ADR 0045 refactors Phase 3 so each mission maps to a scientific domain of the Psychopharmacological Agent Model.

## Created Artifacts

- `KnowledgeBase/SSRIs/DrugProfiles/ScientificProfile/SCIENTIFIC_DRUG_PROFILE_SCHEMA.json`
- `KnowledgeBase/SSRIs/DrugProfiles/ScientificProfile/SCIENTIFIC_DRUG_PROFILE_MODEL.json`
- `KnowledgeBase/SSRIs/DrugProfiles/ScientificProfile/SCIENTIFIC_DRUG_PROFILE_INDEX.json`
- `KnowledgeBase/SSRIs/DrugProfiles/ScientificProfile/SCIENTIFIC_DRUG_PROFILE_TRACEABILITY.json`
- `KnowledgeBase/SSRIs/DrugProfiles/ScientificProfile/SCIENTIFIC_DRUG_PROFILE_VALIDATION.json`

## Core Profiles Initialized

- `SSRI_FLUOXETINE`
- `SSRI_SERTRALINE`
- `SSRI_ESCITALOPRAM`
- `SSRI_CITALOPRAM`
- `SSRI_PAROXETINE`
- `SSRI_FLUVOXAMINE`

## Boundary Candidates

The following candidates remain excluded from the core SSRI profiles:

- Vilazodone
- Vortioxetine

They remain pending ontology decision and are not populated in this mission.

## Explicit Non-Scope

This mission did not create:

- mechanism of action values;
- receptor binding values;
- pharmacokinetic values;
- pharmacodynamic values;
- indications;
- posology;
- contraindications;
- safety statements;
- interactions;
- adverse effects;
- monitoring guidance;
- evidence classification;
- recommendation;
- prescription;
- runtime object.

## Traceability

The profile shells are traceable to the portfolio and editorial registries:

- `KnowledgeBase/SSRIs/Metadata/DRUG_PORTFOLIO_DEFINITION.json`
- `KnowledgeBase/SSRIs/Registries/DRUG_PORTFOLIO_EDITORIAL_REGISTRY.json`
- `KnowledgeBase/SSRIs/Traceability/DRUG_SOURCE_BINDING.json`

Field-level scientific traceability remains pending future domain missions.

## Validation

Structural validation passed for:

- six core SSRI profile shells;
- unique profile IDs;
- boundary candidate exclusion;
- absence of populated scientific values;
- disabled runtime consumption;
- absence of recommendation and prescription artifacts.

## Next Mission

`A03-022 - MECHANISM_OF_ACTION_MODELING`

## Declaration Final

A03-021 initializes the structural Scientific Drug Profile layer for SSRIs. It does not create clinical content, recommendations, prescriptions or runtime-consumable knowledge.
